GENE ONLINE|News &
Opinion
Blog

R&D
Gilead Adds Jounce to its Long List of Oncology Partnerships
2020-09-03
Spotlight: The Revitalization of Chronic Migraine Therapies
2020-09-02
Spotlight: Infusion-Related Reactions Associated with Rapid Infusion of Daratumumab
2020-08-31
Bristol-Myers-Squibb Anticipates FDA Approval for CC-486 as a Treatment for Acute Myeloid Leukemia
2020-08-30
A New Imaging Tool Predicts Response of Cancer Patients to Immune Checkpoint Inhibition Therapy
2020-08-30
Novartis’ Asciminib Shines in Chronic Myeloid Leukemia Trial
2020-08-28
FDA Okays Foundation Medicine’s Comprehensive Liquid Biopsy Test
2020-08-27
Bristol Myers Squibb to Acquire Forbius for Augmenting TGF-beta Inhibitors
2020-08-25
Newly Created Immune-Evading Human Islets Could Potentially Treat Diabetes
2020-08-24
TET2 – A Master Switch to Turn off Parkinson Disease Symptoms
2020-08-22
Alzheon’s Bags $47 Million from NIA for Oral Alzheimer’s Drug
2020-08-22
A Novel Tool to Augment Checkpoint Inhibitor Cancer Therapy
2020-08-19
Genentech’s IL-6 Inhibitor Bags FDA Approval for Neuromyelitis Optica Spectrum Disorder
2020-08-19
OneOncology Enters First-of-its-Kind Partnership with FMI to Advance Personalized Medicine at Community Oncology Practices
2020-08-18
R&D
Altering the Treatment Landscape of Neurodegenerative Diseases Using Antisense Oligonucleotides (ASOs)
2020-08-17
1 24 25 26 27 28 34
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top